Health-Related Quality of Life (HRQOL) with Pembrolizumab or Observation for High-Risk Muscle-Invasive Urothelial Carcinoma after Surgery, Results from the AMBASSADOR Randomized Trial (A031501)
   Google Scholar   
Citation:
J Clin Oncol vol 44 (16_suppl) 4513
Meeting Instance:
ASCO 2026
Year:
2026
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Health Outcomes
Sec. Committees:
GU    
Pharmas:
Merck  
Grants:
U10CA180821, U10CA180882, UG1CA189823  
Corr. Author:
 
Authors:
               
Networks:
KANSAS, LAPS-MA036, LAPS-MN026, LAPS-NY016, MD001   
Study
Alliance-A031501
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: